Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2015 - Issue 3
Submit an article Journal homepage
606
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Determinants of Long-Term Persistence with Tiotropium Bromide for Chronic Obstructive Pulmonary Disease

Kyuto TanakaDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan;Kawasaki Municipal Hospital, Kanagawa, Japan
,
Nobufumi KamiishiDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
,
Jun MiyataDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
,
Hiroki KabataDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
,
Katsunori MasakiDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
,
Hiromi Ogura-TomomatsuDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan;Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan
,
Katsuyoshi TomomatsuDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan;Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan
,
Yusuke SuzukiDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
,
Koichi FukunagaDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
,
Koichi SayamaDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan;Kawasaki Municipal Hospital, Kanagawa, Japan
,
Tomoko BetsuyakuDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
&
Koichiro AsanoDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan;Kawasaki Municipal Hospital, Kanagawa, JapanCorrespondence[email protected]
 show all
Pages 234-242 | Published online: 05 Aug 2014

References

  • Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19:217–224.
  • O’Donnell DE, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23:832–840.
  • Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005; 128:1168–1178.
  • Anzueto A, Tashkin D, Menjoge S, et al. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther 2005; 18:75–81.
  • Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359:1543–1554.
  • Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60:925–931.
  • Niewoehner DE, Rice K, Cote C, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med 2005; 143:317–326.
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: 2011 update. http://www.goldcopd.com
  • Cramer JA, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 2007; 14:25–29.
  • Wedzicha JA, Calverley PM, Seemungal TA, et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008; 177:19–26.
  • Vogelmeier C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011; 364:1093–1103.
  • Ágh T, Inotai A, Mészáros Á. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration 2011; 82:328–334.
  • Decramer M, Molenberghs G, Liu D, et al. Premature discontinuation during the UPLIFT study. Respir Med 2011; 105:1523–1530.
  • Laforest L, Denis F, Van Ganse E, et al. Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J 2010; 19:148–154.
  • American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107–1136.
  • Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol 1982; 33:379–387.
  • Smith BM, Schwartzman K, Kovacina B, et al. Lung cancer histologies associated with emphysema on computed tomography. Lung Cancer 2012; 76:61–66.
  • Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178:738–744.
  • National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001; 345:1075–1083.
  • Breekveldt-Postma NS, Koerselman J, Erkens JA, et al. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med 2007; 101:1398–1405.
  • Breekveldt-Postma NS, Gerrits CM, Lammers JW, et al. Persistence with inhaled corticosteroid therapy in daily practice. Respir Med 2004; 98:752–759.
  • Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 2006; 118:899–904.
  • Jung E, Pickard AS, Salmon JW, et al. Medication adherence and persistence in the last year of life in COPD patients. Respir Med 2009; 103:525–534.
  • Donohue JF, van Noord JA, Bateman ED, et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122:47–55.
  • van Noord JA, Aumann JL, Janssens E, et al. Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms. Respir Med 2010; 104:995–1004.
  • Mahler DA, D’Urzo A, Bateman ED, et al. Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison. Thorax 2012; 67:781–788.
  • Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: The Nippon COPD Epidemiology study. Respirology 2004; 9:458–465.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.